TR-14035 is a orally active dual α 4 β 7 /α 4 β 1 integrin antagonist, with IC 50 s of 7 nM and 87 nM for α 4 β 7 and α 4 β 1 , respectively. TR-14035 can be used for the research of inflammation and autoimmune diseases.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Integrin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.